Adage Capital Partners’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
Other funds holding MIRM
Adage Capital Partners's MIRM Position: Q3 2026 in Review
Adage Capital Partners reduced its Mirum Pharmaceuticals (MIRM) stake by 50% in Q3 2026, selling an estimated $18.3M and leaving 174,762 shares worth $14.9M. The position accounts for 0.02% of the portfolio, ranked #621.
Adage Capital Partners first reported a position in MIRM in Q3 2023 and has held it in 13 quarters since. The position peaked at $41M in Q2 2026. 317 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.
- Adage Capital Partners held 174,762 shares of Mirum Pharmaceuticals worth $14.9M as of Q3 2026.
- Adage Capital Partners sold 175,238 Mirum Pharmaceuticals shares in Q3 2026, an estimated $18.3M.
- Mirum Pharmaceuticals made up 0.02% of Adage Capital Partners's portfolio in Q3 2026, its #621 holding.
- Adage Capital Partners first reported a position in Mirum Pharmaceuticals in Q3 2023 and has held it in 13 quarters since.
- Adage Capital Partners's Mirum Pharmaceuticals position peaked at $41M in Q2 2026.
- 317 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.
Based on Adage Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.